Application of Dithiocarbamate Complexes as Metallotherapy and Medical Imaging Agent

Ajibade, P. A., & Zulu, H. N. (2023). Synthesis, crystal structure, and photocatalytic application of bis(diallyldithiocarbamato)metal complexes. Journal of Inorganic Biochemistry, 240, Ali, M., & Shahzadi, S. (2017). Dithiocarbamate complexes of first-row transition metals: A review of biological applications. Bioinorganic Chemistry and Applications, 2017, 1–18. Barros, L. A., & Costa, P. R. (2018). Recent advances in the design of dithiocarbamate metal complexes for medical applications. European Journal of Medicinal Chemistry, 156, 583– Casas, J. S., & Sordo, J. (2011). Coordination Chemistry of Dithiocarbamates and Related Ligands. Springer. Cvek, B., & Dvorak, Z. (2008). Targeting of nuclear factor-?B and proteasome by dithiocarbamate complexes with anticancer activity. Current Pharmaceutical Design, 14(30), 3015–3027. Gibson, D. (2020). The mechanism of action of platinum anticancer agents—what do we really know about it? Dalton Transactions, 49(3), 1297–1307. Hartinger, C. G., & Dyson, P. J. (2009). Bioorganometallic chemistry—from teaching paradigms to medicinal applications. Chemical Society Reviews, 38(2), 391–401. Kratz, F., Müller, I. A., Ryppa, C., & Warnecke, A. (2008). Prodrug strategies in anticancer chemotherapy. ChemMedChem, 3(1), 20–53. Ma, D., & Lin, W. (2010). Dithiocarbamate-based Gd(III) MRI contrast agents: Design and in vivo imaging applications. Chemical Communications, 46(22), 3959–3961. Maurya C and Bajpai S. (2022). Biological Applications of Metal Complexes of Dithiocarbamates , J. Appl. Sci. Educ., 2 (1), 1–16, Ngoshe A. M. (2024). Medicinal Importance of Dithiocarbamate Complexes: Potential Agents in Management of Diabetes. Int. Journ. Chem. and Chem. Proc., 10 (6), 51-59. E-ISSN 2545-5265 P-ISSN 2695-1916, doi: 10.56201/ijccp.v10(6) 51.59 Pasqualini, R., & Arap, W. (2004). Functionalized nanoparticles for molecular imaging and therapy. Nature Reviews Drug Discovery, 3(9), 798–807. Ramogida, C. F., & Orvig, C. (2013). Tumour targeting with radiometals for diagnosis and therapy. Chemical Communications, 49(42), 4720–4739. Ronconi, L., & Sadler, P. J. (2007). Using coordination chemistry to design new medicines. Coordination Chemistry Reviews, 251(13-14), 1633–1648. Srivastava V. K (2021).Synthesis and Pharmacological Evaluation of Molybdenum Complex with Biologically active Ligand, Sch Int J Chem Mater Sci ISSN 2617-6556. DOI: 10.36348/sijcms.2021.v04i11.008 SwissADME – A web tool for evaluating pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. http://www.swissadme.ch/ Tella T, Pohl C.H and Ayangbenro A. (2022). A review of the therapeutic properties of dithiocarbamates 11:243 https://doi.org/10.12688/f1000research.109553. Tralau-Stewart, C.J., Wyatt P, Gaulton A and Overington J.P (2022). ADMET and the Rule of Five in 2022: Trends, Challenges, and Misconceptions. Drug Discovery Today, 27(9), 2496–2503. https://doi.org/10.1016/j.drudis.2022.05.007 Tsopelas, C., & Sutton, R. (2011). Technetium-99m radiopharmaceuticals for molecular imaging: an overview. Australasian Radiology, 55(3), 222–230. Zolle, I. (2007). Technetium-99m Pharmaceuticals: Preparation and Quality Control in Nuclear Medicine. Springer-Verlag. Wahid S, Jahangir S, Versiani M.A and Khan K.M et al., (2022). Biology-oriented drug synthesis of nitrofurozone derivatives: Their ?-glucosidase inhibitory activity and molecular docking studies. Arab. J. Chem. https://doi.org/10.1016/j.arabjc.2022.103806 1878-5352